Rheumatoid Arthritis Cardiovascular Risk Remains High In DMARD Era

November 16, 2006 – 8:48 pm | posted in Arthritis, Bones / Orthopaedics, Pain / Anesthetics

The increased risk of cardiovascular disease and myocardial infarction associated with rheumatoid arthritis does not appear to have been changed by the introduction of DMARDs, according to a Swedish study.

Dr Ulf Bergstrom and colleagues, University Hospital Malmo, compared cardiovascular morbidity and mortality in 1995-2002, and in an earlier patient cohort (1978-85).

They found that the increased incidence of cardiovascular events and cardiovascular deaths in patients with RA remained unchanged over time, despite intensive treatment with newer anti-rheumatic drugs and reduced disease severity, and they call for further action to prevent cardiovascular co-morbidity (Abstract #335).

Popularity: 2% [?]

Share This

Also Read

Sex — A Major Predictor Of Remission In Early Rheumatoid Arthritis?

Smoking And Rheumatoid Arthritis - Evidence Of Harm Accumulates

Heavy Toll Of Obesity On Rheumatoid Arthritis Quality Of Life

Predicting The Risk Of Rheumatoid Arthritis For Early Arthritis Patients

UCB Announces Positive Results From Two New Phase III Studies In Rheumatoid Arthritis

Trial Results Will Help In Treatment Of Arthritis

Immune Cells Get Together In The Lung Of Patients With Rheumatoid Arthritis

Celebrex Approved To Treat Juvenile Rheumatoid Arthritis

Phytomedics’ Novel Oral Disease Modifying Drug Candidate PMI-001 Demonstrates Positive Phase II Results In Rheumatoid Arthritis

Actemraâ„¢ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme